Yubo International Biotech Limited
YBGJ
$0.0163
-$0.0097-37.31%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.41M | -1.83M | -1.78M | -2.00M | -1.42M |
| Total Depreciation and Amortization | 180.50K | 181.40K | 183.30K | 256.00K | 254.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -122.40K | 6.00K | 5.50K | 73.00K | -272.60K |
| Change in Net Operating Assets | -26.80K | -198.80K | -197.10K | 264.80K | 122.20K |
| Cash from Operations | -1.38M | -1.85M | -1.78M | -1.41M | -1.31M |
| Capital Expenditure | 0.00 | 12.70K | 0.00 | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | 116.40K | 118.50K | 118.50K | 118.50K | 82.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 11.10K | 0.00 | 0.00 | 0.00 |
| Cash from Investing | 116.40K | 142.30K | 118.50K | 118.50K | 82.00K |
| Total Debt Issued | 1.51M | 1.55M | 1.48M | 1.19M | 1.19M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 102.20K | 276.60K | 374.60K | 297.80K | 272.40K |
| Cash from Financing | 1.61M | 1.82M | 1.85M | 1.49M | 1.46M |
| Foreign Exchange rate Adjustments | -342.00K | -162.10K | -182.20K | -190.70K | -226.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.70K | -42.20K | 5.70K | 7.80K | 7.60K |